Page last updated: 2024-08-24

triazoles and Morbid Obesity

triazoles has been researched along with Morbid Obesity in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Brüggemann, RJM; Burger, DM; Knibbe, CAJ; Smit, C; van Dongen, EPA; van Donselaar, MH; Verweij, PE; Wasmann, RE; Wiezer, RMJ	1
Chan, LN; Chen, KF; Lin, YS	1
de Boer, H; de Jong, J; Hermus, A; Loves, S; Tack, CJ; Telting, D; van Sorge, A; Westerterp, K	1
Amory, JK; Page, ST; Roth, MY	1
de Boer, H; Jansen, M; Ruinemans-Koerts, J; Verschoor, L	1

Trials

3 trial(s) available for triazoles and Morbid Obesity

Article	Year
Implications for IV posaconazole dosing in the era of obesity. The Journal of antimicrobial chemotherapy, 2020, 04-01, Volume: 75, Issue:4 Topics: Antifungal Agents; Humans; Obesity, Morbid; Prospective Studies; Triazoles	2020
Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia. European journal of endocrinology, 2013, Volume: 169, Issue:5 Topics: Adult; Androgens; Aromatase Inhibitors; Blood Glucose; Body Composition; Body Mass Index; Bone Density; Double-Blind Method; Energy Intake; Estradiol; Exercise Tolerance; Hormones; Humans; Hypogonadism; Letrozole; Lipid Metabolism; Luteinizing Hormone; Male; Middle Aged; Neuropsychological Tests; Nitriles; Obesity, Morbid; Psychometrics; Testosterone; Triazoles	2013
Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:3 Topics: Aromatase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Gonadotropins, Pituitary; Humans; Hypogonadism; Letrozole; Male; Middle Aged; Nitriles; Obesity, Morbid; Pilot Projects; Sex Hormone-Binding Globulin; Testosterone; Triazoles	2005

Other Studies

2 other study(ies) available for triazoles and Morbid Obesity

Article	Year
PBPK modeling of CYP3A and P-gp substrates to predict drug-drug interactions in patients undergoing Roux-en-Y gastric bypass surgery. Journal of pharmacokinetics and pharmacodynamics, 2020, Volume: 47, Issue:5 Topics: Acetaminophen; Administration, Oral; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Digoxin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Gastric Bypass; Gastrointestinal Absorption; Hepatobiliary Elimination; Humans; Intestinal Elimination; Metabolic Clearance Rate; Midazolam; Models, Biological; Obesity, Morbid; Postoperative Period; Triazoles; Verapamil	2020
Treatment of male infertility secondary to morbid obesity. Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:7 Topics: Adult; Anastrozole; Aromatase Inhibitors; Follicle Stimulating Hormone; Humans; Hypogonadism; Infertility, Male; Luteinizing Hormone; Male; Nitriles; Obesity, Morbid; Spermatogenesis; Testosterone; Triazoles	2008

Article

Year

PBPK modeling of CYP3A and P-gp substrates to predict drug-drug interactions in patients undergoing Roux-en-Y gastric bypass surgery.

Journal of pharmacokinetics and pharmacodynamics, 2020, Volume: 47, Issue:5

Topics: Acetaminophen; Administration, Oral; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Digoxin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Gastric Bypass; Gastrointestinal Absorption; Hepatobiliary Elimination; Humans; Intestinal Elimination; Metabolic Clearance Rate; Midazolam; Models, Biological; Obesity, Morbid; Postoperative Period; Triazoles; Verapamil

2020

Treatment of male infertility secondary to morbid obesity.

Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:7

Topics: Adult; Anastrozole; Aromatase Inhibitors; Follicle Stimulating Hormone; Humans; Hypogonadism; Infertility, Male; Luteinizing Hormone; Male; Nitriles; Obesity, Morbid; Spermatogenesis; Testosterone; Triazoles

2008